NOV 17, 2020 5:00 AM PST

Utilizing rapid diagnostics and new methods to quickly diagnose sepsis

Sponsored by: Bruker Daltonics
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Laboratory Manager Microbiology and Virology
    Biography
      Francis Yongblah is the Laboratory Manager and In-Service Trainee Consultant Clinical Scientist, in the Microbiology and Virology department at Great Ormond Street Hospital (GOSH), London, UK. Francis has worked as a Healthcare Scientist for over 10 years and has a wealth of knowledge and experience in Microbiology. In addition to running and managing the service at GOSH, Francis is heavily involved in research to improve patient outcomes, within the department at GOSH, as well forming collaborations with UCL and other NHS laboratories. Francis is part of the team working on precision AMR which is an exciting project working to utilize rapid diagnostics to improve antibiotic prescribing and working towards preventing the threat of Antimicrobial Resistance (AMR). Part of this project will be focusing on the improved use of MALDI Biotyper® and utilizing it to improve patient outcomes.

    Abstract
    Date: November 17, 2020
    Time: 5:00am (PST), 8:00am (EST), 2:00pm (CET)
     
    Septicemia is a serious clinical condition with roundabout 123,000 cases of sepsis a year in England. In recent years there have been great advances in improving time to identification of pathogens causing sepsis. One of the key methods is the Bruker MBT Sepsityper® IVD Kit which can be used together with the MALDI Biotyper® for fast identification of causative pathogens from Positive Blood Cultures. This presentation looks at the clinical benefits of using the Bruker Sepsityper® solution to improve patient treatment and management. Although the Sepsityper® method has improved diagnosis, the initially introduced full extraction workflow could be further improved in terms of user intervention and reduced time to result. This investigation/presentation also looks at a validation of the new Rapid Sepsityper® workflow, which leads to a much shortened sample preparation procedure for identification of isolates from blood culture bottles, further reducing the time to diagnosis.
     
    Learning Objectives
    • Improving the identification of pathogens by the MALDI Biotyper®
    • Using the MBT Sepsityper® IVD Kit for rapid identification of pathogens from Positive Blood Cultures
    • Validation of the Rapid Sepsityper® Workflow

     

    Please contact your local representative for availability in your country. Not for sale in the USA.

     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more